Eli Lilly extends tender offer to buy Point Biopharma to Dec. 15 (updated)

POINT Biopharma Global

04/12/2023 12:17

(Adds details in paragraph 2)
       Dec 4 (Reuters) - Eli Lilly  LLY.N , on Monday, gave
Point Biopharma Global  PNT.O  shareholders more time to sell
their stock to the drugmaker amid low participation since the
offer price was below the current stock price of the radiopharma
developer.
    Eli Lilly's new deadline is Dec. 15 but maintained its offer
price at $12.50 per share despite it being more than 10% lower
than Point's share price of $13.8 at close on Friday. 

 (Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi
Majumdar)
 ((Mariam.ESunny@thomsonreuters.com;))